🔎 Trials Near Me

Dachaigh › Aillse a' bhroilleach › Indiana

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Indiana

Tha 35 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann an Indiana.

Bailtean ann an Indiana

Teacsa sgrùdaidh oifigeil (Beurla)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Community Health Network, Inc, Indianapolis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Investigative Clinical R of Indiana, Indianapolis
A’ fastadhÌre 3
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Reid Health, Richmond
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Fort Wayne
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07205822

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 45 · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT05557877

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Community Health Network, Indianapolis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06324357

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Fort Wayne Medical Oncology and Hematology ( Site 0084), Fort Wayne
  • Franciscan Health ( Site 0077), Indianapolis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Northwest Cancer Center, Dyer
  • Indiana University, Indianapolis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07214532

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Indiana University (IU) School of Medicine, Indianapolis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Indiana University Health University Hospital, Indianapolis
  • Deaconess GI Specialty Center, Newburgh
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Sult 2026 · NCT07287098

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Northwest Cancer Centers, PC, Dyer
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06492616

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

  • IU Health Joe and Shelly Schwarz Cancer Center, Carmel
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT05846789

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Goshen Center for Cancer Care, Goshen
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07211178

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • IU Health West Hospital, Avon
  • IU Health North Hospital, Carmel
  • UChicago Medicine Northwest Indiana, Crown Point
  • agus 12 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 60 · Banairean · Air ùrachadh 2 Sult 2026 · NCT05879926

HER2 Vaccine for Locally Advanced Breast Cancer

  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06949410

HER-2 B Cell Peptide Vaccine

  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianpolis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06414733

E-Mindfulness Approaches for Living After Breast Cancer

  • Goshen Center for Cancer Care, Goshen
  • Baptist Health Floyd, New Albany
  • Memorial Hospital of South Bend, South Bend
A’ fastadhÌre 3
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06748222

Integrated Cancer Repository for Cancer Research

  • Parkview Research Center, Fort Wayne
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

Exercise in Metastatic Breast Cancer: EMBody

  • Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT05468034

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • Northwest Cancer Center - Main Campus, Crown Point
  • UChicago Medicine Northwest Indiana, Crown Point
  • Northwest Oncology LLC, Dyer
  • agus 9 a bharrachd
A’ fastadhÌre 3
Aoisean 50 gu 70 · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT04852887

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

  • Indiana University, Indianapolis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT04841148

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05735080

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Woodland Cancer Care Center, Michigan City
  • Reid Health, Richmond
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

  • Research Site, Indianapolis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06956690

NearWave Optical Molecular Monitoring

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
A’ fastadh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Gearr 2026 · NCT06744465

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Floyd, New Albany
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • Deaconess Chancellor Center for Oncology, Newburgh
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT06401421

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Franciscan Health Indianapolis, Indianapolis
  • Franciscan Saint Elizabeth Health - Lafayette East, Lafayette
  • Franciscan Health Mooresville, Mooresville
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Dàmh 2025 · NCT03418961

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  • Parkview Health, Fort Wayne
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2025 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

  • Northwest Cancer Center, Dyer
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Ògmh 2025 · NCT06568692

BostonGene and Exigent Genomic INsight Study

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2025 · NCT06272864

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.